These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 399908)

  • 1. The mutagenicity of dialkyl nitrosamines in the Salmonella plate assay.
    Prival MJ; King VD; Sheldon AT
    Environ Mutagen; 1979; 1(2):95-104. PubMed ID: 399908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines.
    Kuroki T; Drevon C; Montesano R
    Cancer Res; 1977 Apr; 37(4):1044-50. PubMed ID: 321116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of some dialkylnitrosamines, cyclic nitrosamines and N,N-diethanolnitrosamine in Salmonella typhimurium with rat and rabbit nasal, lung and liver S9 homogenates.
    Dahl AR
    Mutat Res; 1985 Dec; 158(3):141-7. PubMed ID: 3908927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P; Gingell R
    Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicities of N-nitrosamines on Salmonella.
    Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T
    Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of N-nitrosopyrrolidine derivatives in Salmonella (Ames) and Escherichia coli K-12 (343/113) assays.
    Rao TK; Cox JT; Allen BE; Epler JL; Lijinsky W
    Mutat Res; 1981 May; 89(1):35-43. PubMed ID: 7017389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella.
    Mori Y; Yamazaki H; Toyoshi K; Emi Y; Uchida K; Tsutsumi M; Konishi Y
    Mutat Res; 1985 Apr; 142(4):153-8. PubMed ID: 3885018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of beta-oxidized N,N,-di-n-propylnitrosamine derivatives in S. typhimurium mediated by rat and hamster tissues.
    Camus A; Bertram B; Krüger FW; Malaveille C; Bartsch H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):293-302. PubMed ID: 136104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutagenicity of heterocyclic N-nitrosamines for Salmonella typhimurium.
    Zeiger E; Sheldon AT
    Mutat Res; 1978 Mar; 57(1):1-10. PubMed ID: 347283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher efficiency of hamster hepatocytes than rat hepatocytes for detecting dimethylnitrosamine and diethylnitrosamine in hepatocyte-mediated Chinese hamster V79 cell mutagenesis assay.
    Katoh Y; Tanaka M; Takayama S
    Mutat Res; 1982 Oct; 105(4):265-9. PubMed ID: 7133033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity and rat-liver S9 demethylation kinetics of N-nitrosomethylaniline and its ring-substituted derivatives.
    Kroeger-Koepke MB; Andrews AW; Kupper RJ; Koepke SR; Michejda CJ
    Mutat Res; 1981 Aug; 89(4):255-67. PubMed ID: 7027031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol (vitamin A) inhibition of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN) induced sister-chromatid exchanges in V79 cells and mutations in Salmonella/microsome assays.
    Huang CC
    Mutat Res; 1987 Mar; 187(3):133-40. PubMed ID: 3547112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.